$AMPX
Amprius Technologies, Inc. Stock $ampx

$ampx Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000189928723000076 Filed on May 11, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$1.632M	$679.0K	$2.110M
YoY Change	136.18%	-67.82%	1375.52%
Cost Of Revenue	$4.664M	$4.104M	$3.149M
YoY Change	124.12%	30.33%	177.2%
Gross Profit	-$3.032M	-$3.425M	-$1.039M
YoY Change	118.13%	229.64%	4.63%
Gross Profit Margin	-185.78%	-504.42%	-49.24%
Selling, General & Admin	$6.279M	$5.526M	$1.502M
YoY Change	170.65%	267.91%	188.29%
% of Gross Profit
Research & Development	$772.0K	$800.0K	$369.0K
YoY Change	71.18%	116.8%	6.65%
% of Gross Profit
Depreciation & Amortization	$500.0K	$400.0K	$334.0K
YoY Change	28.21%	19.76%	5.7%
% of Gross Profit
Operating Expenses	$7.051M	$6.326M	$1.871M
YoY Change	154.46%	238.11%	115.8%
Operating Profit	-$10.08M	-$9.751M	-$114.4K
YoY Change	503.14%	8423.3%	343.05%
Interest Expense	$640.0K	$650.0K	$0.00
YoY Change	9042.86%		-100.0%
% of Operating Profit
Other Income/Expense, Net	$635.0K	$649.0K	-$141.4K
YoY Change	-86.05%	-558.88%	1920.44%
Pretax Income	-$9.450M	-$9.102M	-$2.878M
YoY Change	127.49%	216.26%	53.99%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$9.400M	-$9.100M	-$255.8K
YoY Change	-426.28%	3456.98%	890.76%
Net Earnings / Revenue	-575.98%	-1340.21%	-12.12%
Basic Earnings Per Share	-$0.11	-$0.11	-$0.04
Diluted Earnings Per Share	-$0.11	-$0.11	-$34.19K
COMMON SHARES
Basic Shares Outstanding	84.97M shares	84.63M shares	65.77M shares
Diluted Shares Outstanding	85.22M shares	84.65M shares	65.77M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$65.01M	$64.19M	$8.616M
YoY Change	1139.94%	644.97%
Cash & Equivalents	$65.00M	$64.20M	$2.651M
Short-Term Investments
Other Short-Term Assets	$4.060M	$4.316M	$1.287M
YoY Change	139.25%	235.35%
Inventory	$503.0K	$845.0K	$339.0K
Prepaid Expenses			$350.0K
Receivables	$1.100M	$600.0K	$471.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$70.70M	$69.90M	$3.001M
YoY Change	3128.65%	2229.34%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.903M	$4.948M	$6.866M
YoY Change	5.24%	-27.93%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$702.0K	$684.0K	$89.00K
YoY Change	-79.82%	668.54%
Total Long-Term Assets	$15.94M	$14.05M	$230.0M
YoY Change	-93.08%	-93.89%
TOTAL ASSETS
Total Short-Term Assets	$70.70M	$69.90M	$3.001M
Total Long-Term Assets	$15.94M	$14.05M	$230.0M
Total Assets	$86.64M	$83.95M	$233.0M
YoY Change	-62.75%	-63.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$597.0K	$1.023M	$71.14K
YoY Change	1911.93%	1338.05%
Accrued Expenses	$7.141M	$3.665M	$149.1K
YoY Change	518.6%	2358.03%
Deferred Revenue	$3.198M	$3.135M
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$12.01M	$8.884M	$220.2K
YoY Change	913.98%	3933.76%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$7.940M	$8.029M	$3.068M
YoY Change	159.82%	161.7%
Total Long-Term Liabilities	$7.940M	$8.029M	$3.068M
YoY Change	159.82%	161.7%
TOTAL LIABILITIES
Total Short-Term Liabilities	$12.01M	$8.884M	$220.2K
Total Long-Term Liabilities	$7.940M	$8.029M	$3.068M
Total Liabilities	$19.95M	$16.91M	$24.07M
YoY Change	-3.84%	-29.73%
SHAREHOLDERS EQUITY
Retained Earnings	-$111.4M	-$102.0M	-$21.04M
YoY Change	507.19%	384.84%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$66.69M	$67.04M	-$21.04M
YoY Change
Total Liabilities & Shareholders Equity	$86.64M	$83.95M	$233.0M
YoY Change	-62.75%	-63.98%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$9.400M	-$9.100M	-$255.8K
YoY Change	-426.28%	3456.98%	890.76%
Depreciation, Depletion And Amortization	$500.0K	$400.0K	$334.0K
YoY Change	28.21%	19.76%	5.7%
Cash From Operating Activities	-$5.590M	-$6.492M	-$413.5K
YoY Change	128.26%	1470.09%	-87.63%
INVESTING ACTIVITIES
Capital Expenditures	$1.730M	$1.140M	-$34.00K
YoY Change	-1181.25%	-3452.94%	-43.33%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$1.730M	-$1.140M	-$230.0M
YoY Change	981.25%	-99.5%	383233.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	8.140M	$2.123M	233.0M
YoY Change	-1988.63%	-99.09%	6726.47%
NET CHANGE
Cash From Operating Activities	-5.590M	-$6.492M	-413.5K
Cash From Investing Activities	-1.730M	-$1.140M	-230.0M
Cash From Financing Activities	8.140M	$2.123M	233.0M
Net Change In Cash	820.0K	-$5.509M	2.574M
YoY Change	-126.97%	-314.04%	25638.25%
FREE CASH FLOW
Cash From Operating Activities	-$5.590M	-$6.492M	-$413.5K
Capital Expenditures	$1.730M	$1.140M	-$34.00K
Free Cash Flow	-$7.320M	-$7.632M	-$379.5K
YoY Change	219.79%	1911.17%	-88.44%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001899287
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201602Member
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P4Y
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-04321
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	AMPRIUS TECHNOLOGIES, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1591811
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	1180 Page Avenue
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Fremont
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94538
CY2023Q1	dei	City Area Code CityAreaCode	800
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	425-8803
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	84971565	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	64187000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	69696000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	555000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	686000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	845000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	500000	usd
CY2023Q1	us-gaap	Deferred Costs Current DeferredCostsCurrent	2475000	usd
CY2022Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	1897000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1841000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2394000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	69903000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	75173000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4948000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4236000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7894000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2751000	usd
CY2023Q1	us-gaap	Deferred Costs DeferredCosts	519000	usd
CY2022Q4	us-gaap	Deferred Costs DeferredCosts	367000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	684000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	644000	usd
CY2023Q1	us-gaap	Assets Assets	83948000	usd
CY2022Q4	us-gaap	Assets Assets	83171000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1023000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1028000	usd
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	3665000	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	2708000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3135000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2660000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1061000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	521000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	8884000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6917000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	902000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	720000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7127000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2501000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	16913000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	10138000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	usd
CY2022Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	950000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	950000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	84971465	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	84971465	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	84610114	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	84610114	shares
CY2023Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	8000	usd
CY2022Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	8000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	169016000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	165912000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-101989000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-92887000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	67035000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	73033000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	83948000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	83171000	usd
CY2023Q1	us-gaap	Revenues Revenues	679000	usd
CY2022Q1	us-gaap	Revenues Revenues	2110000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	4104000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	3149000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	-3425000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	-1039000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	800000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	369000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5526000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1502000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	6326000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	1871000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-9751000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2910000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	649000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	32000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-9102000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2878000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	84645097	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	84645097	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	65774528	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65774528	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	73033000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2376000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	723000	usd
CY2023Q1	ampx	Adjustments To Additional Paid In Capital Contribution From Parent Related To Stock Based Compensation AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation	3000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-9102000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	67035000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	13858000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	8000	usd
CY2022Q1	ampx	Adjustments To Additional Paid In Capital Capital Contributions From Parent AdjustmentsToAdditionalPaidInCapitalCapitalContributionsFromParent	247000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	350000	usd
CY2022Q1	ampx	Adjustments To Additional Paid In Capital Contribution From Parent Related To Stock Based Compensation AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation	106000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2878000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	11537000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-9102000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2878000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	726000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	456000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	416000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	358000	usd
CY2023Q1	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	134000	usd
CY2022Q1	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	1252000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	202000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	140000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-131000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	209000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	345000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-161000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	864000	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	595000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-553000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-41000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	59000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-51000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	1120000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-332000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	657000	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1300000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-179000	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-86000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6492000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3043000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1140000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	34000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1140000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-34000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2389000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2023Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	268000	usd
CY2022Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2000	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8000	usd
CY2023Q1	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	0	usd
CY2022Q1	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	247000	usd
CY2023Q1	ampx	Payment Of Transaction And Issuance Costs In Connection With Business Combination And Pipe Investment PaymentOfTransactionAndIssuanceCostsInConnectionWithBusinessCombinationAndPIPEInvestment	0	usd
CY2022Q1	ampx	Payment Of Transaction And Issuance Costs In Connection With Business Combination And Pipe Investment PaymentOfTransactionAndIssuanceCostsInConnectionWithBusinessCombinationAndPIPEInvestment	51000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2123000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	204000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5509000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2873000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	69752000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11489000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	64243000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8616000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	64187000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8616000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	56000	usd
CY2022Q1	us-gaap	Restricted Cash RestrictedCash	0	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	64243000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8616000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-9100000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-102000000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	64200000	usd
CY2023Q1	ampx	Committed Equity Financing CommittedEquityFinancing	197600000	usd
CY2022Q4	ampx	Government Assistance Grant Not Yet Received GovernmentAssistanceGrantNotYetReceived	50000000	usd
CY2022Q3	ampx	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	1.45590
CY2023Q1	ampx	Number Of Executive Employees Of Parent Sharing Facilities Costs NumberOfExecutiveEmployeesOfParentSharingFacilitiesCosts	2	executiveemployee
CY2023Q1	ampx	Number Of Executive Employees Of Parent Sharing Facilities Costs NumberOfExecutiveEmployeesOfParentSharingFacilitiesCosts	2	executiveemployee
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4000000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3400000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances; the results of which form the basis for making judgements that are not readily apparent from other sources. Actual results could materially differ from management estimates using different assumptions or under different conditions. </span></div>Our significant accounting estimates include useful lives of property, plant and equipment; valuation of deferred taxes; lower of cost or net realizable adjustment of inventory; carve-out of financial statements including the allocation of assets, liabilities and expenses prior to the Business Combination; incremental borrowing rate used in calculating lease obligations and right-of-use assets; and fair value of common stock prior to the Business Combination and other inputs used to value stock-based compensation awards.
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	56000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	56000	usd
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Concentration of Credit RiskAccounts receivable mainly consist of amounts due from U.S. government agencies or sponsored entities and large public entities which limits our credit risk. Through March 31, 2023, we have not experienced any credit losses.
CY2022Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2900000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	120000	usd
CY2023Q1	us-gaap	Revenues Revenues	679000	usd
CY2022Q1	us-gaap	Revenues Revenues	2110000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	600000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	700000	usd
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	300000	usd
CY2022Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	usd
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1400000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	11000000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	7100000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	3900000	usd
CY2023Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	164000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	180000	usd
CY2023Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	395000	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	218000	usd
CY2023Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	286000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	102000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	845000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	500000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12608000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11480000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7660000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7244000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4948000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4236000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	400000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	400000	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2406000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	481000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1105000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1840000	usd
CY2023Q1	ampx	Accrued Offering Costs Current AccruedOfferingCostsCurrent	31000	usd
CY2022Q4	ampx	Accrued Offering Costs Current AccruedOfferingCostsCurrent	194000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	123000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	193000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3665000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2708000	usd
CY2023Q1	ampx	Shares Authorized SharesAuthorized	1000000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	950000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	7700000	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	47720836	shares
CY2022Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	726000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	456000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2023Q1	ampx	Lessee Finance Lease Number Of Leases LesseeFinanceLeaseNumberOfLeases	0	lease
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y3M18D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.079
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5200000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	179000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	202000	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	140000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	822000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1126000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1158000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1193000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1241000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1278000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	4729000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	11547000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	3359000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	8188000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-9102000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9102000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2878000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-2878000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	84645097	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	84645097	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65774528	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	65774528	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	61986915	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10351020	shares

Files In Submission

Name	View Source	Status
0001899287-23-000076-index-headers.html	Edgar Link	pending
0001899287-23-000076-index.html	Edgar Link	pending
0001899287-23-000076.txt	Edgar Link	pending
0001899287-23-000076-xbrl.zip	Edgar Link	pending
ampx-20230331.htm	Edgar Link	pending
ampx-20230331.xsd	Edgar Link	pending
ampx-20230331xexhibit311.htm	Edgar Link	pending
ampx-20230331xexhibit312.htm	Edgar Link	pending
ampx-20230331xexhibit321.htm	Edgar Link	pending
ampx-20230331xexhibit322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
ampx-20230331_cal.xml	Edgar Link	unprocessable
ampx-20230331_def.xml	Edgar Link	unprocessable
ampx-20230331_lab.xml	Edgar Link	unprocessable
ampx-20230331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ampx-20230331_htm.xml	Edgar Link	completed
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AMPX
Amprius Technologies, Inc. Stock $ampx

2023 Q2 Form 10-Q Financial Statement

#000189928723000076 Filed on May 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMPX Amprius Technologies, Inc. Stock $ampx

2023 Q2 Form 10-Q Financial Statement

#000189928723000076 Filed on May 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMPX
Amprius Technologies, Inc. Stock $ampx